Microbot Medical (MBOT) Depreciation & Amortization (CF) (2010 - 2026)

Microbot Medical (MBOT) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $12000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 20.0% year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44000.0 (down 43.59% YoY) and the FY2025 annual result came in at $47000.0, down 48.35% from the prior year.
• Depreciation & Amortization (CF) improved to $12000.0 in Q1 2026, from $10000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $35000.0 in Q4 2023 to a low of $10000.0 in Q3 2025.
• A 5-year average of $21058.8 and a median of $23000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 64.29% — and 2025, when it sank 61.54%.
• Tracing MBOT's Depreciation & Amortization (CF) over 5 years: stood at $33000.0 in 2022, then climbed by 6.06% to $35000.0 in 2023, then retreated by 25.71% to $26000.0 in 2024, then slumped by 61.54% to $10000.0 in 2025, then rose by 20.0% to $12000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $12000.0 (Q1 2026), $10000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.